我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

含臭参复方对实验性便秘的影响及作用机制研究(PDF)

《云南中医学院学报》[ISSN:1000-2723/CN:53-1048/R]

期数:
2017年05期
页码:
18-22
栏目:
实验研究
出版日期:
2017-12-16

文章信息/Info

Title:
Influence of Compound Chinese Medicine Containing Codonopsis pilosula Producedin Yunnan Province on Purgation and Its Primary Action Mechanism
作者:
杨园12胡晓玉123桑秋2程永现123△
1. 云南中医学院,云南 昆明 650500;2. 中国科学院昆明植物研究所植物化学与西部植物资源持续利用国家重点实验室,云南 昆明 650201;3. 深圳大学医学部药学院,广东 深圳 518060
Author(s):
YANG Yuan12 HU Xiaoyu2 SANG Qiu2 CHENG Yongxian123
1. Yunnan University of Traditional Chinese Medicine,Kunming 650500,China;2. State Key Laboratory of Phytochemistry and Plant Resources in West China,Kunming Institute of Botany,Chinese Academy of Sciences,Kunming 650201,China;3. School of Pharmaceutical Sciences,Shenzhen University Health Science Center,Shenzhen 518060,China
关键词:
臭参云南参便秘通便
Keywords:
Codonopsis pilosula Yunnan Shen constipation defecation
分类号:
R285.5
DOI:
10.19288/j.cnki.issn.1000-2723.2017.05.004
文献标识码:
A
摘要:
目的 探讨臭参为君的复方对实验性便秘的影响及初步作用机制。方法 通便实验中,复方地芬诺酯混悬液灌胃造成小鼠便秘模型,采用观察首便时间、便粒数、便重3项指标以观察含臭参复方的通便作用;并且采用小鼠炭末推进实验,来观察小肠推进运动。将小鼠随机分为对照组、模型组、不同给药剂量组(0.41g·kg-1、0.82g·kg-1、1.64g·kg-1、3.28g·kg-1)。各组给药30min后,均以浓度为4%的墨汁进行灌胃,观察小鼠肠推进运动的变化。结果 在通便实验中,首便时间、便粒数、便重3项指标中,模型组较空白组均有显著性降低(P<0.001),其中3.28g·kg-1剂量组其首便时间与模型组比较显著缩短(P<0.05),便重与便粒数与模型组比较显著增加(P<0.01);小鼠炭末推进实验中,模型组的肠推进率较对照组显著降低(P<0.001),给药组的肠推进率显著高于模型组(P<0.05),给药5d的肠推进率高于给药1d和3d的效果,并呈现一定的量效关系或趋势。结论 以云南产臭参为君的中药复方对实验性便秘具有改善作用,初步机理研究表明其可能与促进肠推进相关。
Abstract:
Objective To study the effects of compound Chinese medicine containing Codonopsis pilosula produced in Yunnan province(known as Choushen) on promoting digestion and purgation. Methods Mice were randomly divided into control group, model group and different dosage groups(0.41g·kg-1, 0.82g·kg-1, 1.64g·kg-1, 3.28g·kg-1). The time of the first stool, grain numbers of stool, stool weight in mice, the propulsion rate of intestine, after administration were observed. Results In the mice defecation test, the time of the first stool(227.75±38.82min) at the dosage of 3.28g·kg-1 was much shorter compared with the model group(269.38±44.41min)(P<0.05). The stool weight(0.537±0.203g) of 3.28g·kg-1 group was heavier versus the model group(0.242±0.178g)(P<0.01). In addition, the grain numbers of stool (22.63±6.14) of highest group also significantly increased when compared with model group(13.75±8.24)(P<0.01). In the mice digestion test,the intestinal propulsive rate of the treatment group was significantly higher than that of the model group(P<0.05), the intestinal propulsive rate of 5-day administration was higher than that of 1 day or 3 days. Conclusion The present compound Chinese medicine containing C.pilosula possesses significant effects on purgation promotion and this effect might be associated with digestion promotion, suggesting its potential roles in the development of healthcare foods.

参考文献/References

[1] Wald A,Scarpignato C,Mueller-Lissner S,et al.A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation[J]. Alimentary Pharmacology & Therapeutics,2008,28(7):917-930.
[2] 麦玉书. 便秘的现代中医文献整理及循证医学研究[D]. 广州:广州中医药大学,2011.
[3] Webster L,Dhar S,Eldon M,et al.A phase 2,double-blind,randomized,placebo-controlled,dose-escalation study to evaluate the efficacy,safety,and tolerability of naloxegol in patients with opioid-induced constipation[J]. Pain,2013,154(9):1542-1550.
[4] Irving G,Pénzes J,Ramjattan B,et al.A randomized,placebo-controlled phase 3 trial(study SB-767905/013)of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain[J]. The Journal of Pain,2011,12(2):175-184.
[5] Thomas J.Opioid-induced bowel dysfunction[J]. Journal of Pain and Symptom Management,2008,35(1):103-113.
[6] Mei RQ,Lv Q,Hu YF,et al.Chemical constituents from Codonopsis cordifolioidea[J]. Natural Product Research & Development,2010,22(2):238-240.
[7] 刘品华,赵利敏,张鸭光,等. 臭参地上部分酶水解条件及黄酮、多糖的研究[J]. 食品研究与开发,2016,37(6):64-67.
[8] 程永现,胡敏,吕青. 一种促消化和排毒养颜的中药或食品和其制备方法与应用ZL201210517935.8[P]. 2013-02-20.
[9] 刘品华,刘明研,张鸭关,等. 臭参营养成分的研究[J]. 云南农业大学学报(自然科学),2015,30(3):418-423.
[10] 卫生部. 保健食品功能学评价程序与检验方法规范[M]. 北京:北京大学出版社,2003.
[11] 郑慧伶,李艳霞,张翠丽,等. 四种小鼠便秘模型建立方法的比较[J]. 现代生物医学进展,2013,13(28):5456-5459.
[12] 李根林,张颜语,李寒冰. 复方地芬诺酯建立大鼠便秘模型及对肠道菌群的影响[J]. 中国组织工程研究,2016,20(49):7404-7410.
[13] Liang C,Wang KY,Yu Z,et al.Development of a novel mouse constipation model[J]. World Journal of Gastroenterol,2016,22(9):2799-2810.
[14] 董丽丹,钱子刚,杨兆祥,等. 臭参的降血脂抗疲劳及抗缺氧作用研究[J]. 云南中医中药杂志,2015,36(3):66-68.
[15] 杨国汉,胡德耀,戴裕光,等. 藿香正气液促进小鼠肠推进作用的时效性和量效性分析[J]. 实用中医药杂志,2005,21(11):649-650.
[16] 林子洪,吴敬勋,肖梓栋,等. 芦荟对小鼠便秘的作用及其机制初探[J]. 广东医学,2005,26(10):1336-1338.
[17] 解欣然,洪缨,樊江波. 复方芦荟胶囊药理作用的实验研究[J]. 中国实验方剂学杂志,2007,13(11):47-49.
[18] Kojima R,Nozawa K,Doihara H,et al.Effects of novel TRPA1 receptor agonist ASP7663 in models of drug-induced constipation and visceral pain[J]. European Journal of Pharmacology,2014,723(1):288-293.
[19] 苏丽珍. 浅谈便秘的危害及防范对策[J]. 医学信息,2011,24(7):4363.
[20] Ma FL,Shen XM,Shi J,et al.The efficacy trials and researches of codonopsis polysaccharide on improving digestive functions[J]. Medicinal Plant,2013,4(11-12):43-47.
[21] 樊英,李天保,刁菁,等. 党参对仿刺参免疫和消化功能的影响[J]. 中国饲料,2017(7):20-25.
[22] 王曦宇,刘迎雪,徐岩,等. 黄芪党参桂枝汤合半夏厚朴汤治疗功能性消化性不良脾虚肝郁证的临床疗效观察[J]. 中药药理与临床,2015(1):337-338.

备注/Memo

备注/Memo:
* 基金项目: 云南省科技厅重大项目(2014FC002)
收稿日期: 2017 - 09- 16
作者简介: 杨园(1992-),女,河北石家庄人,在读硕士研究生,研究方向:中药药理。
△通信作者: 程永现,E-mail:yxcheng@mail.kib.ac.an
更新日期/Last Update: 2017-10-20